<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – Facilities & Other Resources (Phase I)</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="Facilities & Other Resources: computing environment, software stack, public data sources, and reproducibility controls (version pinning, checksums, deterministic artifacts) for PromptGenix SBIR Phase I."/>

  <style>
    * { box-sizing: border-box; }
    body{
      margin:0;
      font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",sans-serif;
      background:#020617;
      color:#e5e7eb;
      line-height:1.5;
    }
    a{ color:inherit; text-decoration:none; }
    .page{ min-height:100vh; display:flex; flex-direction:column; }

    header{
      position:sticky; top:0; z-index:30;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.3);
    }
    .nav{
      max-width:1120px; margin:0 auto; padding:14px 20px;
      display:flex; align-items:center; justify-content:space-between; gap:18px;
    }
    .nav-left{ display:flex; align-items:center; gap:12px; }
    .logo-dot{
      width:28px; height:28px; border-radius:999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow:0 0 18px rgba(56,189,248,.7);
    }
    .brand{ font-size:1.1rem; font-weight:650; letter-spacing:.04em; }
    .subbrand{ font-size:.72rem; color:#9ca3af; margin-top:2px; }

    .nav-links{ display:flex; gap:10px; flex-wrap:wrap; justify-content:flex-end; }
    .nav-links a{
      font-size:.88rem; color:#9ca3af;
      padding:6px 10px; border-radius:999px;
      border:1px solid rgba(148,163,184,0.18);
      background: rgba(2,6,23,0.25);
    }
    .nav-links a:hover{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.35);
    }
    .nav-links a.active{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.55);
    }

    main{ flex:1; }
    .section{
      max-width: 1120px;
      margin: 0 auto;
      padding: 28px 20px 34px;
    }

    .topline{
      display:flex; flex-wrap:wrap; gap:10px;
      align-items:flex-end; justify-content:space-between;
      padding-top: 16px;
      margin-bottom: 14px;
    }
    .doc-title{
      font-size: 1.35rem;
      font-weight: 820;
      color:#f9fafb;
      margin: 0;
    }
    .meta{
      font-size:.78rem;
      color:#9ca3af;
    }

    .kicker{
      font-size: .78rem;
      text-transform: uppercase;
      letter-spacing: .18em;
      color: #a5b4fc;
      margin: 18px 0 6px;
    }
    h2{
      font-size: 1.12rem;
      font-weight: 760;
      color:#f9fafb;
      margin: 12px 0 8px;
    }
    p{
      margin: 0 0 10px;
      font-size: .95rem;
      color:#d1d5db;
    }

    .grid-2{
      display:grid;
      grid-template-columns: minmax(0,1.05fr) minmax(0,1fr);
      gap:18px;
      margin-top: 10px;
      align-items:start;
    }
    .grid-3{
      display:grid;
      grid-template-columns: repeat(3, minmax(0,1fr));
      gap:18px;
      margin-top: 10px;
      align-items:start;
    }
    .card{
      border-radius: 16px;
      padding: 14px 16px;
      background: rgba(15,23,42,0.84);
      border: 1px solid rgba(148,163,184,0.28);
      box-shadow: 0 18px 45px rgba(15,23,42,0.55);
    }
    .card h3{
      margin: 0 0 8px;
      font-size: .95rem;
      letter-spacing: .14em;
      text-transform: uppercase;
      color:#a5b4fc;
    }

    ul{
      margin: 6px 0 0;
      padding-left: 1.1rem;
      color:#d1d5db;
      font-size: .94rem;
    }
    li{ margin-bottom: 6px; }
    li strong{ color:#e5e7eb; }

    .pill-row{ display:flex; flex-wrap:wrap; gap:8px; margin-top:10px; }
    .pill{
      font-size:.74rem;
      padding: 5px 9px;
      border-radius: 999px;
      border: 1px solid rgba(129,140,248,0.45);
      background: rgba(2,6,23,0.25);
      color:#c7d2fe;
    }

    .callout{
      border-radius: 14px;
      padding: 12px 14px;
      border: 1px dashed rgba(148,163,184,0.5);
      background: rgba(15,23,42,0.75);
      font-size: .92rem;
      color:#e5e7eb;
      margin-top: 12px;
    }
    .callout strong{ color:#22c55e; }

    /* Table */
    .table{
      width:100%;
      border-collapse: collapse;
      margin-top: 10px;
      overflow:hidden;
      border-radius: 14px;
      border: 1px solid rgba(148,163,184,0.28);
      background: rgba(15,23,42,0.6);
    }
    .table th, .table td{
      padding: 12px 12px;
      border-bottom: 1px solid rgba(148,163,184,0.18);
      vertical-align: top;
      font-size: .95rem;
      color:#e5e7eb;
    }
    .table th{
      font-size: .82rem;
      text-transform: uppercase;
      letter-spacing: .14em;
      color:#a5b4fc;
      background: rgba(2,6,23,0.35);
    }

    footer{
      border-top:1px solid rgba(31,41,55,0.9);
      padding:16px;
      font-size:.78rem;
      color:#6b7280;
      text-align:center;
    }

    @media (max-width: 980px){
      .grid-2, .grid-3{ grid-template-columns: minmax(0,1fr); }
    }

    /* Print */
    @media print {
      header, footer { display: none !important; }
      body { background:#fff !important; color:#111 !important; }
      p, li, td, th { color:#111 !important; }
      h1, h2, h3, .kicker { color:#111 !important; }
      * { box-shadow: none !important; }
      @page { size: Letter; margin: 0.5in; }
      .section { max-width: 100% !important; padding: 0 !important; }
      .card{ border: 1px solid #111 !important; background:#fff !important; }
      .table{ border: 1px solid #111 !important; background:#fff !important; }
      .table th{ background:#fff !important; }
      .callout{ border: 1px dashed #111 !important; background:#fff !important; }
    }
  </style>
</head>

<body>
<div class="page">
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div class="subbrand">SBIR Portal</div>
        </div>
      </div>
      <nav class="nav-links">
        <a href="index.html">Portal</a>
        <a href="sbir.html">SBIR</a>
        <a href="aims.html">Aims</a>
        <a href="approach.html">Approach</a>
        <a href="commercialization.html">Commercialization</a>
        <a href="facilities.html" class="active">Facilities</a>
        <a href="team.html">Team</a>
        <a href="use-cases.html">Use Cases</a>
      </nav>
    </div>
  </header>

  <main>
    <section class="section">
      <div class="topline">
        <h1 class="doc-title">Facilities &amp; Other Resources (Phase I)</h1>
        <div class="meta">
          PromptGenix LLC &middot; Contact: dohoon.kim1@icloud.com &middot; promptgenix.org
        </div>
      </div>

      <div class="kicker">Summary</div>
      <p>
        Phase I development and validation will be performed using a modern workstation + optional cloud burst capacity,
        an open-source bioinformatics/ML stack, and <strong>public</strong> biomedical repositories (datasets + literature).
        The environment is designed to be <strong>auditable and deterministic</strong>: pinned versions, captured configs,
        and checksummed artifacts enable reproducible evidence objects and stable hypothesis ranking outputs.
      </p>

      <div class="callout">
        <strong>Key design choice:</strong> Confidence is computed by an evidence-weighted Bayesian decision engine; LLMs are used only for
        interpretability (evidence-linked rationale + citations) under “no evidence → no claim” constraints.
      </div>

      <div class="kicker">Computing environment</div>
      <div class="grid-2">
        <div class="card">
          <h3>Primary development</h3>
          <ul>
            <li><strong>Workstation:</strong> macOS and/or Linux development environment for pipeline engineering, testing, and report generation.</li>
            <li><strong>Local execution:</strong> accession-driven runs, caching of intermediate artifacts, and deterministic re-runs for regression tests.</li>
            <li><strong>Storage:</strong> structured project directories with immutable run outputs (configs + logs + evidence objects + reports).</li>
          </ul>
          <div class="pill-row">
            <span class="pill">Deterministic runs</span>
            <span class="pill">Immutable artifacts</span>
            <span class="pill">Checksums</span>
            <span class="pill">Audit logs</span>
          </div>
        </div>

        <div class="card">
          <h3>Optional scalable compute</h3>
          <ul>
            <li><strong>Cloud burst (optional):</strong> containerized or VM-based execution for larger public datasets and parallel jobs.</li>
            <li><strong>Batch execution:</strong> reproducible job definitions with pinned dependencies and resource-limited profiles.</li>
            <li><strong>Security boundary:</strong> Phase I uses public datasets only; no sensitive/private data required for feasibility.</li>
          </ul>
          <div class="callout" style="margin-top:10px;">
            <strong>Phase I boundary:</strong> all validation uses public sources (datasets + literature) to minimize IP/data-use conflicts.
          </div>
        </div>
      </div>

      <div class="kicker">Software &amp; pipeline stack</div>
      <div class="grid-3">
        <div class="card">
          <h3>Omics pipelines</h3>
          <ul>
            <li><strong>RNA-Seq / scRNA-Seq:</strong> standard alignment/quantification + QC + differential analysis + pathway scoring.</li>
            <li><strong>Flow cytometry:</strong> QC + harmonization + summary features + cell-type/marker-level evidence extraction.</li>
            <li><strong>Evidence objects:</strong> effect size, uncertainty, quality, and context descriptors produced per dataset.</li>
          </ul>
        </div>

        <div class="card">
          <h3>Inference &amp; ranking</h3>
          <ul>
            <li><strong>Bayesian updating:</strong> priors from structured biology + literature signals updated by evidence likelihoods.</li>
            <li><strong>Uncertainty:</strong> posterior confidence with credible intervals + explicit supporting vs. conflicting evidence coverage.</li>
            <li><strong>Calibration tests:</strong> held-out checks to verify confidence behavior and robustness to heterogeneity.</li>
          </ul>
        </div>

        <div class="card">
          <h3>Interpretability & outputs</h3>
          <ul>
            <li><strong>LLM guardrails:</strong> narrative constrained to evidence objects + citations; no hallucinated claims.</li>
            <li><strong>Reports:</strong> exportable HTML/PDF with ranked hypotheses, confidence bands, evidence links, and next-step experiments.</li>
            <li><strong>Traceability:</strong> every claim points to evidence artifacts or cited literature sources.</li>
          </ul>
        </div>
      </div>

      <div class="kicker">Public data sources</div>
      <table class="table" aria-label="Public data sources table">
        <thead>
          <tr>
            <th style="width:26%;">Source category</th>
            <th style="width:44%;">Examples</th>
            <th style="width:30%;">How used in Phase I</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><strong>Public omics datasets</strong></td>
            <td>GEO / SRA (bulk RNA-Seq, scRNA-Seq), curated public immunology studies</td>
            <td>Accession-driven retrieval; evidence extraction (effect sizes, uncertainty, context) and re-run reproducibility tests</td>
          </tr>
          <tr>
            <td><strong>Immune profiling</strong></td>
            <td>FlowRepository and other public cytometry resources</td>
            <td>Harmonization + summary evidence signals; cross-dataset consistency checks for hypothesis ranking</td>
          </tr>
          <tr>
            <td><strong>Scientific literature</strong></td>
            <td>PubMed / PMC (open abstracts/full text where available)</td>
            <td>Literature-derived priors and citation grounding; support vs. conflict signal extraction for traceable explanations</td>
          </tr>
          <tr>
            <td><strong>Knowledge resources</strong></td>
            <td>Pathway and gene-set resources (e.g., KEGG/Reactome-like sets), marker panels, cell-type references</td>
            <td>Prior construction features (pathway relevance, cell specificity); standardized hypothesis templates</td>
          </tr>
        </tbody>
      </table>

      <div class="kicker">Reproducibility controls</div>
      <h2>Version pinning + checksums + immutable artifacts.</h2>

      <div class="grid-2">
        <div class="card">
          <h3>What is pinned and captured</h3>
          <ul>
            <li><strong>Code + configs:</strong> repository commit hash and per-run configuration snapshot.</li>
            <li><strong>Dependencies:</strong> pinned package versions (Python/R), tool versions, and runtime metadata.</li>
            <li><strong>Inputs:</strong> accessions, retrieval timestamps, and input-file manifests.</li>
            <li><strong>Artifacts:</strong> evidence objects, intermediate outputs, and final reports stored immutably per run.</li>
          </ul>
        </div>

        <div class="card">
          <h3>How outputs are verified</h3>
          <ul>
            <li><strong>Checksums:</strong> per-file SHA-256 checksums for key artifacts (evidence objects, figures, reports).</li>
            <li><strong>Determinism tests:</strong> same inputs/configs should reproduce the same artifacts (within defined tolerances).</li>
            <li><strong>Run logs:</strong> structured logs capturing steps, warnings, and evidence coverage (supporting/conflicting/missing).</li>
            <li><strong>Audit trail:</strong> ranked hypotheses link back to evidence objects and cited sources.</li>
          </ul>
        </div>
      </div>

      <div class="callout">
        <strong>Reviewer-facing deliverable:</strong> Each Phase I pilot run produces a compact, verifiable package:
        (1) run manifest, (2) pinned versions + config, (3) evidence object bundle, (4) hypothesis ranking outputs with uncertainty,
        and (5) HTML/PDF report with traceable links.
      </div>

      <div class="kicker">Availability</div>
      <p style="margin-bottom:0;">
        All resources required for Phase I feasibility (compute, software stack, and public data access) are available to execute the proposed work.
        The system is designed to support scalable Phase II deployments (secure VPC/on-prem) without changing the core reproducibility guarantees.
      </p>
    </section>
  </main>

  <footer>
    PromptGenix &middot; SBIR Portal &middot;
    <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
  </footer>
</div>
</body>
</html>
